Details of the Drug Reposition

General Information of This Drug (ID: DMZ51EX)

• Drug Name: BCL201 (DMZ51EX)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Follicular lymphoma	DISVEUR6	2A80	Phase 1	[1]
Mantle cell lymphoma	DISFREOV	2A85.5	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)